APA (7th ed.) Citation

Motzer, R., Escudier, B., Burotto, M., Powles, T., Apolo, A., Bourlon, M., . . . van Kooten Losio, M. (2026). Final analysis of nivolumab plus cabozantinib for advanced renal cell carcinoma from the randomized phase III CheckMate 9ER trial. Annals of Oncology, 37(1), 33. https://doi.org/10.1016/j.annonc.2025.09.006

Chicago Style (17th ed.) Citation

Motzer, R.J, et al. "Final Analysis of Nivolumab Plus Cabozantinib for Advanced Renal Cell Carcinoma from the Randomized Phase III CheckMate 9ER Trial." Annals of Oncology 37, no. 1 (2026): 33. https://doi.org/10.1016/j.annonc.2025.09.006.

MLA (9th ed.) Citation

Motzer, R.J, et al. "Final Analysis of Nivolumab Plus Cabozantinib for Advanced Renal Cell Carcinoma from the Randomized Phase III CheckMate 9ER Trial." Annals of Oncology, vol. 37, no. 1, 2026, p. 33, https://doi.org/10.1016/j.annonc.2025.09.006.